Merck Emend (aprepitant) For Oral Suspension, 125 Mg, Single-dose Kit, Rx Only, Manufactured For: Merck Sharpe & Dohme Llc, Rahway, Nj 07065, Usa, Manufactured By: Novo Nordisk Production Ireland Lim
Recall Summary Merck is recalling Emend (aprepitant) 125 mg oral suspension single-dose kits nationwide because the product may contain metal particles. This is a Class I recall, meaning there is a serious potential health risk. The affected medication was distributed across all U.S. states and the District of Columbia.
- Recalling firm
- Merck Sharp & Dohme LLC
- Product
- Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03
- Reason
- Presence of particulate matter: potential presence of metal particulates in the product.
- Classification
- Class I
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2025-12-12
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- Nationwide in the USA
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/11182b1f-5887-4478-b2cd-39cd8cb00524